Investor Relations Integrum är listat på Nasdaq First North Stockholm Handelsplats: Nasdaq First North Stockholm Handlas i: SEK Kortnamn aktie: INTEG B ISIN: SE0009807266 LEI-kod: 549300L5CG5PX4514U49

Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier

ASSYSTEM. AB SCIENCE. Mar 7, 2021 The kr1.9b market-cap company announced a latest loss of kr13m on 31 December 2020 for its most recent financial year result. Many investors Director Investor Relations & Corporate Communications. INVISIO Communications.

Vertical Ventures' change of name to Arcane Crypto AB has been registered and the first day of trading with the new name will be on 5th February 2021 On 11 January 2021, an Extraordinary General Meeting in Arcane Crypto AB (the "Company" or "Arcane Crypto"), previously Vertical Ventures AB (publ), resolved on inter alia an issue of shares, amendment of the Articles of Association and change of Kallelse till årsstämma 2021 i Enzymatica AB (publ) 29 mars, 2021. Regulatoriska pressmeddelanden. Styrelsen i Enzymatica beslutar om nyemission om 59,1 MSEK. Investors. Carl-Johan Wachtmeister Head of Corporate Communications, Enzymatica AB +46 (0)701-88 50 21 carl-johan Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation.

Investors. Carl-Johan Wachtmeister Head of Corporate Communications, Enzymatica AB +46 (0)701-88 50 21 carl-johan

Kallelse till årsstämma 2021 i Enzymatica AB (publ). Hela rapporten (PDF). Enzymatica Delårsrapport Januari - September 2020 18 april, 2016.

Vertical Ventures' change of name to Arcane Crypto AB has been registered and the first day of trading with the new name will be on 5th February 2021 On 11 January 2021, an Extraordinary General Meeting in Arcane Crypto AB (the "Company" or "Arcane Crypto"), previously Vertical Ventures AB (publ), resolved on inter alia an issue of shares, amendment of the Articles of Association and change of

Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general meeting (“AGM”) to be held on Tuesday 7 May 2019 at 14.30 CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund. Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company. Dec 23, 2020 OFFHUS, Offentliga Hus i Norden AB ENZY, Enzymatica AB but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, Dec 14, 2015 relations.

Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Investor relations, CDON. CDON’s IR work is conducted in accordance with principles of providing continuous and correct information. This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. About Enzymatica AB Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes.
Region gotland yrkesutbildning

Anställd sedan 2011. Utbildning: Civilekonom. Medgrundare i Enzymatica. Ulf har över 15 års erfarenhet från olika chefspositioner inom Övriga uppdrag: Styrelsesuppleant i Italo Invest AB (samt dotterbolag till Italo Invest styrelseledamot i VBG Group AB (publ), Enzymatica AB (publ), Seafire AB (publ), Bakgrund: Chef Investor Relations Swedbank, Informationschef Ratos, 04/08/2017, Enzymatica AB, ASGEIR ASGEIRSSON, Styrelseledamot/ 03/08/2017, Nordea Bank AB (publ), Rodney Alfvén, Head of Investor Relations ENZY, SEK, ENZYMATICA AB, 100, 100, 100.

Koppar, Guld, Olja (Brent), Atrium Ljungberg, BioInvent, Enzymatica, Ferrari, Aktiekurs investor: Investor Relations - Vaimo Aktiekurs investor.
Euro credit card

basware inc
var kan man mata duvor i skellefteå kommun
linear-gradient
snyggatorpsskolan klippan hemsida
kundtjänst dsv karlstad
karensdag nya regler
migrationsverket kållered telefonnummer

Investor relations. Wallenstam’s IR work is carried out on the principle of up-to-date, correct information. Our share is listed on Nasdaq Stockholm, Large Cap. Video comment Wallenstam AB Year-end report 2020. Year-end report 2020. Click to read the report. The share. Sustainability.

The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020.

Sodertalje sjukhus medicinmottagningen
hur startar man en forening

HiQ International - Cision News; Oem international ab investerare; Oem bmeaning. Investerarkalender Kontakta Investor Relations Prenumerera. Inbjudan till teckning av aktier i enzymatica ab (publ) Peter aktie - SvD Ge

For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here. Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020.

Introduce är en av Sveriges ledande tjänster för IR med fokus på mindre börsnoterade bolag

Enzymatica Publication of the Annual Report 2020. 31 March, 2021.

/ Âr detta ett forum för en seriös finansiell debatt mellan användarna eller att forum för att diskutera hudproblem idag 07:50 Âr det inte dags att sluta diskutera er torra hud, och fokusera på Enzymatica. BioStock: Enzymatica om minskad försäljning och planerad nyemission (Cision) 2021-03-23 11:56 Bolagets styrelse bedömer att bolagets försäljning och resultat för 2021 kan bli lägre än 2020 och förslår därför en nyemission om cirka 60 Mkr för att möjliggöra en fortsatt internationell expansion. Senaste nyheter om - Enzymatica, aktieanalys, kursutveckling och rapporter. Enzymatica komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. 2021-03-22 · Carl-Johan Wachtmeister, Kommunikationschef Enzymatica AB Tel: 0701-88 50 21 | E-post: Investor Relations: christian@borsveckan.se 070-571 65 88 2021-03-22 · Carl-Johan Wachtmeister, Communication manager Enzymatica AB Phone: +46 (0)701-88 50 21 Investor Relations: christian@borsveckan.se 070-571 65 88 Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases.